Luis Posado-Domínguez

10PUBLICATIONS
17CO-AUTHORS
BiomechanicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 27, 2026
Effects of a 12-Week Supervised Exercise Program on Quality of Life, Functional Capacity, and Biological Parameters in Women with Breast Cancer: A Prospective Pilot Program.

Gema Barrientos Vicho, Luis Posado-Dominguez, José David Urchaga

|Dec 24, 2025
Pembrolizumab-Associated Hemophagocytic Lymphohistiocytosis in Clear Cell Renal Carcinoma: Case Report and Literature Review.

Romina Pinto Valdivia, Luis Posado-Domínguez, Maria Escribano Iglesias

|Dec 24, 2025
Steroid-Refractory Cholestatic Immune-Mediated Hepatitis Following Nivolumab Therapy in an Elderly Patient with Metastatic Melanoma: A Rare and Challenging Presentation.

Luis Posado-Dominguez, Jorge Feito-Perez, María Escribano-Iglesias

|Dec 05, 2025
A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors.

Juan Carlos Redondo-González, Luis Posado-Domínguez, Laura Corvo-Félix

|Aug 13, 2025
Prognostic impact of negative TTF-1 biomarker in metastatic lung adenocarcinoma treated with chemo-immunotherapy: a retrospective cohort study.

Luis Posado-Domínguez, Alejandro Olivares-Hernández, Daniel Morchón-Araujo

|Nov 26, 2024
Inflammatory Mesenteric Disease and Sarcoidosis-like Reaction in a Patient with Lung Adenocarcinoma Who Received Pembrolizumab: Paraneoplastic Syndrome, Secondary to Checkpoint Inhibitor or Chance Finding?

Luis Posado-Domínguez, María Escribano-Iglesias, Lorena Bellido-Hernández

Pageof 2

Frequent Collaborators

3 joint publications

Alejandro Olivares-Hernández

3 joint publications

Jonnathan Roldan-Ruiz

2 joint publications

Edel Del Barco-Morillo

2 joint publications

María Martín-Galache